We developed a highly sensitive and specific LAMP assay for Escherichia coli. It does not require DNA extraction and can detect as few as 10 copies. It detected all 36 of 36 E. coli isolates and all 22 urine samples (out of 89 samples tested) that had E. coli. This assay is rapid, low in cost, and simple to perform.
Escherichia coli can cause infections of a variety of extraintestinal sites such as the urinary tract, meninges, and bloodstream (3, 5, 8, (10) (11) (12) 21) . Diagnosis of most extraintestinal E. coli (ExPEC) infections requires bacterial culture, requiring 1 to 2 days of incubation, and subsequent confirmatory testing (6, 17) . Guidance as to the presence or absence of an ExPEC infection at initial presentation could be useful for a patient, especially when attempting to reduce excessive use of antibiotics. Although conventional DNA amplification using PCR can provide fast results, it is not widely used partly because it requires considerable skill and expensive equipment. Recently, loop-mediated isothermal amplification (LAMP), a rapid technique for amplifying DNA has been reported (14, 15) . It requires incubation at a constant temperature (60 to 66°C for 30 to 60 min) and eliminates the need for specialized equipment or expertise. We report here the development and characterization of a LAMP assay to detect urinary E. coli.
Three sets of primers (outer, loop, and inner) were required for the E. coli LAMP assay that were designed by analyzing a conserved region of the E. coli malB gene with Primer Explorer version 3 software (http://primerexplorer.jp/elamp3.0.0/index .html) ( Fig. 1 ). This gene is conserved across diverse lineages of E. coli and is not shared by other gram-negative bacteria except Shigella spp., based on BLAST analysis (http://www.ncbi .nlm.nih.gov/BLAST/) (18) . We considered this region to be appropriate because of its conservation, as well as the rarity of Shigella as a cause of extraintestinal infections.
The LAMP reaction was conducted using methods described previously, with minor modifications (14, 15) . The final LAMP reaction (total, 25 l) contained the three primer pairs in the following concentrations: 0.2 M outer primers, 0.8 M loop primers, and 1.6 M inner primers. The reaction mix also contained 2.5 l of 10ϫ Bst DNA polymerase reaction buffer [1ϫ containing 20 mM Tris-HCl, 10 mM KCl, 10 mM (NH 2 )SO 4 , 2 mM MgSO 4 , 0.1% Triton X-100], 1 l of an 8-U/l concentration of Bst DNA polymerase (New England Biolabs, Inc., MA), 2 mM MgSO 4 (2 l), 5 l of betaine (Sigma-Aldrich, St. Louis, MO), and 5 l of sample. We generated and quantified a plasmid containing the target E. coli sequence to determine the sensitivity of the LAMP assay. The target sequence in E. coli was amplified by PCR using the primers F3 and B3 of the LAMP assay and cloned by using a StrataClone PCR cloning kit (Stratagene, La Jolla, CA). The copy number of the solution containing the E. coli clone was determined by UV spectrophotometry (2) . The analytical sensitivity of LAMP was determined by using 10-fold serial dilutions of the E. coli clone.
The LAMP reaction was performed in a heating block (Lab-Line, Iowa). For comparison, it was also performed using a conventional thermal cycler (Bio-Rad, California), and both machines performed equally well. The cost per reaction was ca. 50¢ (U.S. currency).
A positive E. coli LAMP reaction typically required incubation for 60 min at 66°C to produce a ladder pattern on agarose gel (Fig. 2i ). The E. coli LAMP products from several of the bands in the gel were excised and sequenced. The amplicons matched the E. coli malB gene segment spanned by F3/B3 primers. The E. coli LAMP products were also detected without electrophoresis using ambient light after the addition of a number of DNA dyes to the reaction tube. These dyes included propidium iodide, ethidium bromide, methylene blue, acridine orange, and Sybr green. Of the various dyes, Sybr green (1:10 dilution of a 10,000ϫ stock solution) and propidium iodide (1:10 dilution of 10-mg/ml stock solution) produced the best visual discrimination. For both the dyes, 1 l of the diluted dye was added to 25 l of the reaction mix to develop the color reaction ( Fig.2ii ). UV transillumination of the reaction mix containing the DNA dye improved the differentiation further.
The specificity of the assay was evaluated by testing eight gram-negative bacteria (Acinetobacter spp., Citrobacter freundii, Enterobacter cloacae, Haemophilus influenzae, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Serratia marcescens) and six gram-positive bacteria (Enterococcus faecalis, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes, and Streptococcus viridians). No ladder pattern was seen with any of the other non-E. coli bacteria or with the negative "no-target" control ( Fig. 2i ). The sensitivity of E. coli LAMP was found to be approximately 10 copies per reaction when an incubation period of 60 min was used. Larger copy numbers required shorter incubation times (as low as 15 to 20 min for Ͼ1,000,000 copies).
We further tested a range of E. coli isolates by this assay. A total of 36 isolates of E. coli from unique patients (n ϭ 23) or the Escherichia coli Reference (ECOR) Collection (n ϭ 13) were tested. ECOR (established in 1984) contains 72 strains and five phylotypes (16) . A LAMP assay was performed on an aliquot of bacterial solution without extraction of DNA. It was able to detect all of the 36 E. coli isolates (Table 1) . Finally, 89 fresh urine samples were tested by LAMP assay, and the results were compared to cultured urine samples obtained from microbiology laboratories of the Children's Hospital of Pittsburgh and the All India Institute of Medical Sciences from patients suspected with urinary tract infections (UTI). The culture was considered "positive" if there was growth of individual bacteria in a concentration of Ͼ100,000 colonies/ml. Growth of multiple bacteria was considered contamination. The samples were stored at 4°C after plating of urine and were analyzed by LAMP assay within 1 to 3 days of collection. Initial LAMP testing, performed on three known E. coli-positive urine samples, showed positive results both with and without DNA extraction using a QIAmp DNA Mini-Kit (Qiagen, California). Subsequent tests were performed on unextracted urine, i.e., 5 l of unprocessed urine was directly added to the LAMP reaction mix, followed by incubation for 60 min at 66°C. Of the 89 urine samples, 22 were positive for E. coli, all of which tested positive by the LAMP assay. In addition, 36 samples had no bacterial growth, and the LAMP assay results were negative in all of these samples. Finally, in 31 samples, organisms other than E. coli grew, including 13 samples that pro- duced Ն1 bacterial species. In 29 of these 31 samples, the LAMP assay was negative. Two non-E. coli samples that had tested positive by the LAMP assay had grown multiple organisms and probably had E. coli as one of the contaminants (Tables 2 and 3) . We describe here a new, rapid, and economical assay to detect E. coli in human urine in 1 h (or less), which makes this assay amenable for point-of-care or outpatient settings. There are several advantages of the LAMP over PCR, the conventional method for DNA amplification. This assay only needs a heating block and obviates the need for a thermal cycler. Also, DNA extraction is not required for LAMP. In contrast, unprocessed urine normally requires DNA extraction for PCR, since urinary urea can inhibit PCR at concentrations of Ͼ50 mM and the normal concentration of urea in adult urine is Ͼ330 mM (1, 4, 9, 20) . Hence, the LAMP assay, by eliminating the step of DNA extraction, is more "user friendly" than PCR. We focused on urine as the analyte for the present study and obtained consistent results for all of the culture-positive samples. Although we did not test other biological fluids (e.g., blood, cerebrospinal fluid, etc.) it is likely, based on our recent studies on BK virus LAMP, that E. coli LAMP would perform well with these types of specimens (2) .
Another advantage of this assay is that identification of a positive reaction does not require any special processing or electrophoresis. It could be detected by looking for a color change of the reaction mix in ambient light, when a DNAbinding dye is used. This visualization can be further enhanced by UV transillumination. We also showed that a simple chemical such as propidium iodide can be used for detecting a positive reaction. To our knowledge, this is the first report of using propidium iodide to visualize LAMP products. Pro- pidium iodide is less expensive, does not require freezing for storage, and is more easily available in developing countries, such as India, than is Sybr green. In theory, a deep color of the urine (bilirubin, myoglobin, or other chromogens) could affect the color of the final LAMP products and interfere with the assay results, but we did not see this effect in the range of samples of urine tested that had minor color variation (from clear to pale yellow).
Our assay was able to detect a large number of strains studied with a very high sensitivity. Indeed, the ability to detect 10 copies per reaction may be considered to be "too sensitive" for use as a clinical assay for UTI diagnostics. However, the assay's sensitivity can be lowered to match the conventionally accepted cutoff of Ͼ100,000 copies/ml for urine if a shorter incubation time is used (i.e., 30 to 40 min versus 60 min). It is likely that different levels of sensitivity may be required for different biological fluids. For example, it may be necessary to have a high sensitivity for blood and CSF versus a lower sensitivity for urine for the assays to be clinically meaningful. Also, an ability to detect a lower copy number may be important in partially treated infections (after empirical antibiotic doses), where the organisms are reduced in number or not culturable but the DNA is still detectable.
Although LAMP assays for various specific E. coli strains have been reported, these studies were designed to detect virulence loci or markers of specific strains, such as verotoxin (7, 19, 22) . However, for detection of UTI-associated E. coli strains, a less discriminatory approach is intended. Our studies extend the role of LAMP to the rapid diagnosis of such infections, using this less-biased approach. In addition to the advantages described here, there are some limitations of the assay in its current format. This assay is suited for qualitative but not quantitative information. Possibly, semiquantitative assays can be developed where the time required to develop a positive reaction could be used as a surrogate for the starting copy number. Also, LAMP assays do not provide antimicrobial susceptibility information and since bacteria demonstrate increasing resistance to antimicrobial agents, this assay is more likely to be an adjunct rather than a replacement for culture. Finally, in contrast to culture, this assay detects only a single organism. However, LAMP assays for other common bacterial pathogens, including Staphylococcus spp., have recently been reported (13) ; these assays may potentially be combined with this assay to screen for common infections. Further studies involving a larger number of patients and different specimens are needed in order to evaluate the clinical utility of this assay. 
